FEATURED COMPANIES
- CMIC Co. Ltd
- Covance Inc.
- ICON Plc
- IQVIA Holdings Inc.
- Novotech Pty Ltd
- PRA Health Sciences Inc.
Europe pharmaceutical contract research organization (CRO) market was valued at $12.13 billion in 2021 and will grow by 9.6% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 69 tables and 48 figures, this 140-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year.
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.
For each key country, detailed analysis and data for annual revenue ($bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 69 tables and 48 figures, this 140-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.
Based on Service, the Europe market is segmented into the following sub-markets with annual revenue ($bn) for 2021-2030 included in each section.
- CRO for Pre-clinical Development
- CRO for Phase I Trials
- CRO for Phase II Trials
- CRO for Phase III Trials
- CRO for Phase IV Trials
- Laboratory Services
- Consulting Services
- Data Management Services
Based on Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue ($bn) for 2021-2030 included in each section.
- Infectious Diseases
- Oncology
- Metabolic Disorders
- Cardiovascular Disorders
- Central Nervous System
- Respiratory Disorders
- Gastrointestinal Disorders
- Other Therapeutic Applications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($bn) for 2021-2030 included in each section.
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Companies
- Academic Institutes
Geographically, the following national/local markets are fully investigated:
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
- Charles River Laboratories
- CMIC Co. Ltd
- Covance Inc.
- Hangzhou Tigermed Consulting Co., Ltd.
- ICON Plc
- IQVIA Holdings Inc.
- LSK Europe Pharma Service Co., Ltd.
- Novotech Pty Ltd
- PAREXEL International Corporation
- Pharmaceutical Product Development LLC (PPD)
- PRA Health Sciences Inc.
- Quanticate Ltd
- Samsung Bioepis Co., Ltd.
- SGS SA (SGS Life Sciences)
- Syneos Health Inc.
- WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the European Pharmaceutical Contract Research Organization Market
What is the estimated value of the European Pharmaceutical Contract Research Organization Market?
What is the growth rate of the European Pharmaceutical Contract Research Organization Market?
What is the forecasted size of the European Pharmaceutical Contract Research Organization Market?
Who are the key companies in the European Pharmaceutical Contract Research Organization Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- CMIC Co. Ltd
- Covance Inc.
- ICON Plc
- IQVIA Holdings Inc.
- Novotech Pty Ltd
- PRA Health Sciences Inc.
1 Introduction
2 Market Overview and Dynamics
3 Segmentation of Europe Market by Service
4 Segmentation of Europe Market by Therapeutic Application
5 Segmentation of Europe Market by End User
6 European Market 2019-2030 by Country
7 Competitive Landscape
8 Investing in Europe Market: Risk Assessment and Management
List of Tables:
List of Figures:
Note: Product cover images may vary from those shown
- Charles River Laboratories
- CMIC Co. Ltd
- Covance Inc.
- Hangzhou Tigermed Consulting Co., Ltd.
- ICON Plc
- IQVIA Holdings Inc.
- LSK Global Pharma Service Co., Ltd.
- Novotech Pty Ltd
- PAREXEL International Corporation
- Pharmaceutical Product Development LLC (PPD)
- PRA Health Sciences Inc.
- Quanticate Ltd
- Samsung Bioepis Co., Ltd.
- SGS SA (SGS Life Sciences)
- Syneos Health Inc.
- WuXi AppTec Inc.
Note: Product cover images may vary from those shown
LOADING...